Patents Assigned to Amergen, Inc.
  • MHC class II-peptide conjugates useful in ameliorating autoimmunity
    Patent number: 5468481
    Abstract: The present invention is directed to complexes consisting essentially of an isolated MHC component and an autoantigenic peptide associated with the antigen binding site of the MHC component. These complexes are useful in treating autoimmune disease.
    Type: Grant
    Filed: April 14, 1992
    Date of Patent: November 21, 1995
    Assignee: Amergen, Inc.
    Inventors: Somesh D. Sharma, Brian R. Clark, Bernard L. Lerch